Key facts
- This page summarizes M. Andrew Archambault's Form 4 filing for Keurig Dr Pepper Inc. (KDP).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 24 May 2024, 16:59.
M. Andrew Archambault - 23 May 2024 Form 4 Insider Report for Keurig Dr Pepper Inc. (KDP)
- Reporting relationship
- President, US Refreshment Bev.
- Issuer ticker
- KDP
- Reported as of
- 23 May 2024
- Net transaction value
- -$273,520
- SEC form
- 4
- Accepted by SEC
- 24 May 2024, 16:59:46 UTC
- Prior SEC filing
- 14 Mar 2024
- Next SEC filing
- 12 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Mark Jackson, attorney in fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
M. Andrew Archambault filed Form 4 for Keurig Dr Pepper Inc. (KDP) on 24 May 2024.
Change
- Previous filing in this sequence was filed on 14 Mar 2024.
- Current net transaction value: -$273,520.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
KDP
transaction
Common Stock
Sale
- Transaction value
- $273,520
- Shares
- -8,000
- Change %
- -39%
- Price
- $34.19
- Shares after
- 12,565
- Date
- 23 May 2024
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The price represents the weighted average sales price of the shares that were sold in multiple transactions at prices ranging from $34.185 to $34.190. The reporting person undertakes to provide to the Company, any security holder of the Company or the SEC, upon request, full information regarding the number of shares sold at each separate price.
Footnote F2
Amount of securities beneficially owned following reported transaction reflects the transfer of 3,624 shares in a transaction exempt from Section 16 pursuant to Rule 16a-12.